Revenue
2019
2020
2021
2022
2023
Electromedical Technologies, Inc (EMED)
Price$0.0001Cached quote
Financial statements
| 2023 | 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|---|
| Revenue | $1.3M | $1.1M | $907,362 | $737,958 | $829,737 |
| Gross profit | $1.0M | $888,641 | $708,128 | $543,574 | $591,221 |
| Gross margin | 77.51% | 77.28% | 78.04% | 73.66% | 71.25% |
| Research & development | $231,434 | $92,299 | $215,320 | $31,600 | $82,849 |
| Operating expenses | $3.1M | $2.5M | $4.5M | $3.7M | $2.3M |
| Operating income | −$2.1M | −$1.6M | −$3.8M | −$3.2M | −$1.7M |
| Operating margin | −153.09% | −139.46% | −418.83% | −429.11% | −201.10% |
| EBITDA | −$2.1M | −$1.6M | −$3.8M | −$3.1M | −$1.6M |
| EBITDA margin | −152.76% | −137.55% | −416.41% | −426.15% | −198.16% |
| Net income | −$2.6M | −$3.5M | −$8.5M | −$3.9M | −$1.7M |
| Net profit margin | −195.82% | −301.65% | −934.59% | −524.65% | −210.23% |
| Basic EPSper basic share | $0.00 | -$0.03 | -$0.24 | -$0.20 | -$0.10 |
| Diluted EPSper diluted share | $0.00 | -$0.03 | -$0.24 | -$0.20 | -$0.10 |
Owners
Reported shareholders